CVS Triple Action Astringent

Product NDC: 59779-807
11-digit product format: 597790807
Labeler code: 59779
Product ID: 59779-807_48732d5b-70ac-41cd-86b4-ea45d7ec9c54
Type: HUMAN OTC DRUG
Nonproprietary name: SALICYLIC ACID
Dosage form: LIQUID
Route: TOPICAL
Labeler: CVS Pharmacy
Application: part333D
Marketing category: OTC MONOGRAPH FINAL
Marketing start: 2010-07-08
Marketing end: 0000-00-00
Substance: SALICYLIC ACID
Active strength: 21 mg/mL
NDC exclude flag: E
Listing certified through: 2017-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 4 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	59779-807		I	Inactivated by FDA	2026-10-16
excluded product	product	59779-807		I	Inactivated by FDA	2026-10-16
excluded package	package	59779-807	59779-807-62	I	Inactivated by FDA	2026-10-16
excluded package	package	59779-807	59779-807-31	I	Inactivated by FDA	2026-10-16

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 2 · 88 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	59779-807-31	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	59779-807-62	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	59779-807-31	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	59779-807-62	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	59779-807-31	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	59779-807-62	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	59779-807-31	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	59779-807-62	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	59779-807-31	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	59779-807-62	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	59779-807-31	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	59779-807-62	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	59779-807-31	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	59779-807-62	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	59779-807-31	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	59779-807-62	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	59779-807-31	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	59779-807-62	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	59779-807-31	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	59779-807-62	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	59779-807-31	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	59779-807-62	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	59779-807-31	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	59779-807-62	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	59779-807-31	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	59779-807-62	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	59779-807-31	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	59779-807-62	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	59779-807-31	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	59779-807-62	`1332a3947898…`	`d4bfe170f9cd…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
d5e51f11-ad28-caa4-4b49-4143974782ad	Product name	1	20150831

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
59779-807-31	2019-10-29	C162847	48780-1	960f7f55-d0f1-8e05-e053-dbdaa90a074a	drug facts
59779-807-62	2019-10-29	C162847	48780-1	960f7f55-cca4-8e05-e053-dbdaa90a074a	DRUG FACTS

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
59779-807-31	CVS Triple Action Astringent	250 mL in 1 BOTTLE, PLASTIC	LIQUID	250		2
59779-807-62	CVS Triple Action Astringent	250 mL in 1 BOTTLE, PLASTIC	LIQUID	250		1

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
SALICYLIC ACID	ACTIVE INGREDIENT	O414PZ4LPZ	CVS TRIPLE ACTION ASTRINGENT (SALICYLIC ACID) LIQUID [CVS PHARMACY]	2
SALICYLIC ACID	ACTIVE MOIETY	O414PZ4LPZ	CVS TRIPLE ACTION ASTRINGENT (SALICYLIC ACID) LIQUID [CVS PHARMACY]	2
ALCOHOL	INACTIVE INGREDIENT	3K9958V90M	CVS TRIPLE ACTION ASTRINGENT (SALICYLIC ACID) LIQUID [CVS PHARMACY]	2
BENZOPHENONE	INACTIVE INGREDIENT	701M4TTV9O	CVS TRIPLE ACTION ASTRINGENT (SALICYLIC ACID) LIQUID [CVS PHARMACY]	2
CITRIC ACID MONOHYDRATE	INACTIVE INGREDIENT	2968PHW8QP	CVS TRIPLE ACTION ASTRINGENT (SALICYLIC ACID) LIQUID [CVS PHARMACY]	2
EDETATE DISODIUM	INACTIVE INGREDIENT	7FLD91C86K	CVS TRIPLE ACTION ASTRINGENT (SALICYLIC ACID) LIQUID [CVS PHARMACY]	2
FD&C BLUE NO. 1	INACTIVE INGREDIENT	H3R47K3TBD	CVS TRIPLE ACTION ASTRINGENT (SALICYLIC ACID) LIQUID [CVS PHARMACY]	2
FD&C YELLOW NO. 5	INACTIVE INGREDIENT	I753WB2F1M	CVS TRIPLE ACTION ASTRINGENT (SALICYLIC ACID) LIQUID [CVS PHARMACY]	2
GLYCERIN	INACTIVE INGREDIENT	PDC6A3C0OX	CVS TRIPLE ACTION ASTRINGENT (SALICYLIC ACID) LIQUID [CVS PHARMACY]	2
HAMAMELIS VIRGINIANA LEAF	INACTIVE INGREDIENT	T07U1161SV	CVS TRIPLE ACTION ASTRINGENT (SALICYLIC ACID) LIQUID [CVS PHARMACY]	2
ISOPROPYL ALCOHOL	INACTIVE INGREDIENT	ND2M416302	CVS TRIPLE ACTION ASTRINGENT (SALICYLIC ACID) LIQUID [CVS PHARMACY]	2
MENTHOL	INACTIVE INGREDIENT	L7T10EIP3A	CVS TRIPLE ACTION ASTRINGENT (SALICYLIC ACID) LIQUID [CVS PHARMACY]	2
POLYSORBATE 60	INACTIVE INGREDIENT	CAL22UVI4M	CVS TRIPLE ACTION ASTRINGENT (SALICYLIC ACID) LIQUID [CVS PHARMACY]	2
SODIUM CITRATE	INACTIVE INGREDIENT	1Q73Q2JULR	CVS TRIPLE ACTION ASTRINGENT (SALICYLIC ACID) LIQUID [CVS PHARMACY]	2
SODIUM HYDROXIDE	INACTIVE INGREDIENT	55X04QC32I	CVS TRIPLE ACTION ASTRINGENT (SALICYLIC ACID) LIQUID [CVS PHARMACY]	2
WATER	INACTIVE INGREDIENT	059QF0KO0R	CVS TRIPLE ACTION ASTRINGENT (SALICYLIC ACID) LIQUID [CVS PHARMACY]	2
SALICYLIC ACID	ACTIVE INGREDIENT	O414PZ4LPZ	CVS TRIPLE ACTION ASTRINGENT (SALICYLIC ACID) LIQUID [CVS PHARMACY]	1
SALICYLIC ACID	ACTIVE MOIETY	O414PZ4LPZ	CVS TRIPLE ACTION ASTRINGENT (SALICYLIC ACID) LIQUID [CVS PHARMACY]	1
ALCOHOL	INACTIVE INGREDIENT	3K9958V90M	CVS TRIPLE ACTION ASTRINGENT (SALICYLIC ACID) LIQUID [CVS PHARMACY]	1
BENZOPHENONE	INACTIVE INGREDIENT	701M4TTV9O	CVS TRIPLE ACTION ASTRINGENT (SALICYLIC ACID) LIQUID [CVS PHARMACY]	1
CITRIC ACID MONOHYDRATE	INACTIVE INGREDIENT	2968PHW8QP	CVS TRIPLE ACTION ASTRINGENT (SALICYLIC ACID) LIQUID [CVS PHARMACY]	1
EDETATE DISODIUM	INACTIVE INGREDIENT	7FLD91C86K	CVS TRIPLE ACTION ASTRINGENT (SALICYLIC ACID) LIQUID [CVS PHARMACY]	1
FD&C BLUE NO. 1	INACTIVE INGREDIENT	H3R47K3TBD	CVS TRIPLE ACTION ASTRINGENT (SALICYLIC ACID) LIQUID [CVS PHARMACY]	1
FD&C YELLOW NO. 5	INACTIVE INGREDIENT	I753WB2F1M	CVS TRIPLE ACTION ASTRINGENT (SALICYLIC ACID) LIQUID [CVS PHARMACY]	1
GLYCERIN	INACTIVE INGREDIENT	PDC6A3C0OX	CVS TRIPLE ACTION ASTRINGENT (SALICYLIC ACID) LIQUID [CVS PHARMACY]	1
HAMAMELIS VIRGINIANA LEAF	INACTIVE INGREDIENT	T07U1161SV	CVS TRIPLE ACTION ASTRINGENT (SALICYLIC ACID) LIQUID [CVS PHARMACY]	1
ISOPROPYL ALCOHOL	INACTIVE INGREDIENT	ND2M416302	CVS TRIPLE ACTION ASTRINGENT (SALICYLIC ACID) LIQUID [CVS PHARMACY]	1
MENTHOL	INACTIVE INGREDIENT	L7T10EIP3A	CVS TRIPLE ACTION ASTRINGENT (SALICYLIC ACID) LIQUID [CVS PHARMACY]	1
POLYSORBATE 60	INACTIVE INGREDIENT	CAL22UVI4M	CVS TRIPLE ACTION ASTRINGENT (SALICYLIC ACID) LIQUID [CVS PHARMACY]	1
SODIUM CITRATE	INACTIVE INGREDIENT	1Q73Q2JULR	CVS TRIPLE ACTION ASTRINGENT (SALICYLIC ACID) LIQUID [CVS PHARMACY]	1
SODIUM HYDROXIDE	INACTIVE INGREDIENT	55X04QC32I	CVS TRIPLE ACTION ASTRINGENT (SALICYLIC ACID) LIQUID [CVS PHARMACY]	1
WATER	INACTIVE INGREDIENT	059QF0KO0R	CVS TRIPLE ACTION ASTRINGENT (SALICYLIC ACID) LIQUID [CVS PHARMACY]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
59779-807	CVS TRIPLE ACTION ASTRINGENT (SALICYLIC ACID) LIQUID [CVS PHARMACY]	2	Legacy NDC, 1 package rows	20110801_5e7ff9f9-c68c-4918-9907-620223804641.zip
59779-807	CVS TRIPLE ACTION ASTRINGENT (SALICYLIC ACID) LIQUID [CVS PHARMACY]	1	Legacy NDC, 1 package rows	20110805_f8edb283-05a3-46f9-8960-825c29d48929.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
O414PZ4LPZ	SALICYLIC ACID	69-72-7	SALICYLIC ACID

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
251577	salicylic acid 2 % Topical Solution	PSN	5e7ff9f9-c68c-4918-9907-620223804641	2
251577	salicylic acid 20 MG/ML Topical Solution	SCD	5e7ff9f9-c68c-4918-9907-620223804641	2
251577	salicylic acid 2 % Topical Solution	SY	5e7ff9f9-c68c-4918-9907-620223804641	2
251577	salicylic acid 2 % Topical Solution	PSN	f8edb283-05a3-46f9-8960-825c29d48929	1
251577	salicylic acid 20 MG/ML Topical Solution	SCD	f8edb283-05a3-46f9-8960-825c29d48929	1
251577	salicylic acid 2 % Topical Solution	SY	f8edb283-05a3-46f9-8960-825c29d48929	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Status
59779-807-31	59779080731	250 mL in 1 BOTTLE, PLASTIC	250 ml	Historical
59779-807-62	59779080762	250 mL in 1 BOTTLE, PLASTIC	250 ml	Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
drug facts	CVS Pharmacy \| Pharma Pac, LLC	2010-07-08	HUMAN OTC DRUG LABEL	2
DRUG FACTS	CVS Pharmacy \| Pharma Pac, LLC	2010-07-08	HUMAN OTC DRUG LABEL	1